Off Label Use

The use of a drug (e.g., tretinoin, an analogue of vitamin A) or medical device (e.g., injectable collagen) to treat a condition for which it has not received approval by a regulatory agency—e.g., the FDA. Off-label use is most common in chemotherapy of difficult-to-treat cancers, for which there is no agreement on standardised therapy